BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28710095)

  • 1. Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.
    Holmqvist M; Ljung L; Askling J
    Ann Rheum Dis; 2017 Oct; 76(10):1642-1647. PubMed ID: 28710095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
    Eriksson JK; Jacobsson L; Bengtsson K; Askling J
    Ann Rheum Dis; 2017 Feb; 76(2):364-370. PubMed ID: 27283333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.
    Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
    Ann Rheum Dis; 2019 May; 78(5):683-687. PubMed ID: 30787006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?
    Holmqvist M; Ljung L; Askling J
    Ann Rheum Dis; 2018 Jan; 77(1):85-91. PubMed ID: 28970218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.
    Mantel Ä; Holmqvist M; Nyberg F; Tornling G; Frisell T; Alfredsson L; Askling J
    Arthritis Rheumatol; 2015 Nov; 67(11):2845-54. PubMed ID: 26138387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis.
    Ljung L; Rantapää-Dahlqvist S; Jacobsson LT; Askling J
    Ann Rheum Dis; 2016 Dec; 75(12):2087-2094. PubMed ID: 26984007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
    Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J
    JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
    Ljung L; Simard JF; Jacobsson L; Rantapää-Dahlqvist S; Askling J;
    Arthritis Rheum; 2012 Jan; 64(1):42-52. PubMed ID: 21898355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of New-Onset Acute Coronary Syndrome and Atrial Fibrillation in Patients With Rheumatoid Arthritis Compared With a Risk-Set and Propensity Score-Matched Cohort - A Nationwide Cohort Study.
    Jang SY; Kang KW; Jo M; Park M
    Circ J; 2021 Jan; 85(2):194-200. PubMed ID: 33328426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.
    Mantel Ä; Holmqvist M; Jernberg T; Wållberg-Jonsson S; Askling J
    Ann Rheum Dis; 2017 Dec; 76(12):2017-2024. PubMed ID: 28823986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway.
    Delcoigne B; Provan SA; Kristianslund EK; Askling J; Ljung L
    Eur J Intern Med; 2023 Sep; 115():55-61. PubMed ID: 37355347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries.
    Delcoigne B; Ljung L; Provan SA; Glintborg B; Hetland ML; Grøn KL; Peltomaa R; Relas H; Turesson C; Gudbjornsson B; Michelsen B; Askling J
    Ann Rheum Dis; 2022 Jun; 81(6):789-797. PubMed ID: 35318218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
    Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
    Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is rheumatoid arthritis a risk factor for acute coronary syndrome also among individuals at elevated risk, such as individuals presenting with acute chest pain?
    Svensson P; Bergstrom M; Discacciati A; Ljung L; Jernberg T; Frick M; Linder R; Askling J
    RMD Open; 2020 Nov; 6(3):. PubMed ID: 33243783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statin therapy on the prevention of new-onset acute coronary syndrome in patients with rheumatoid arthritis.
    Huang CY; Lin TT; Yang YH; Lin LY; Tsai CT; Hwang JJ; Chen PC; Lin JL
    Int J Cardiol; 2018 Feb; 253():1-6. PubMed ID: 29174015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome.
    Mantel Ä; Holmqvist M; Jernberg T; Wållberg-Jonsson S; Askling J
    Eur Heart J; 2015 Dec; 36(48):3413-22. PubMed ID: 26400826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
    Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J;
    Ann Rheum Dis; 2015 Jun; 74(6):1212-7. PubMed ID: 24608401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid Arthritis.
    Waldenlind K; Saevarsdottir S; Bengtsson C; Askling J
    JAMA Netw Open; 2018 Oct; 1(6):e183567. PubMed ID: 30646250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis.
    Holmqvist M; Gränsmark E; Mantel A; Alfredsson L; Jacobsson LT; Wallberg-Jonsson S; Askling J
    Ann Rheum Dis; 2013 Apr; 72(4):541-6. PubMed ID: 22610975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
    Eriksson JK; Johansson K; Askling J; Neovius M
    Ann Rheum Dis; 2015 Apr; 74(4):648-54. PubMed ID: 24323395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.